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Artificial intelligence technology has advanced rapidly in recent years and has the potential to 
improve healthcare outcomes. However, technology uptake will be largely driven by clinicians, 
and there is a paucity of data regarding the attitude that clinicians have to this new technology. In 
June–August 2019 we conducted an online survey of fellows and trainees of three specialty colleges 
(ophthalmology, radiology/radiation oncology, dermatology) in Australia and New Zealand on 
artificial intelligence. There were 632 complete responses (n = 305, 230, and 97, respectively), equating 
to a response rate of 20.4%, 5.1%, and 13.2% for the above colleges, respectively. The majority 
(n = 449, 71.0%) believed artificial intelligence would improve their field of medicine, and that medical 
workforce needs would be impacted by the technology within the next decade (n = 542, 85.8%). 
Improved disease screening and streamlining of monotonous tasks were identified as key benefits 
of artificial intelligence. The divestment of healthcare to technology companies and medical liability 
implications were the greatest concerns. Education was identified as a priority to prepare clinicians 
for the implementation of artificial intelligence in healthcare. This survey highlights parallels between 
the perceptions of different clinician groups in Australia and New Zealand about artificial intelligence 
in medicine. Artificial intelligence was recognized as valuable technology that will have wide‑ranging 
impacts on healthcare.
Nomograms and clinical algorithms have long played a role in supporting clinical decision-making in medicine. 
More recently, major advances in research on artificial intelligence (AI) have been applied to medical image 
analysis with promising  results1,2. This technology is now poised for clinical application. In order for AI to fully 
deliver its potential benefits for healthcare, medical practitioners need to understand and embrace the technol-
ogy. Equally, patients need to entrust aspects of their healthcare to AI systems.
Numerous AI image analysis algorithms have been shown to achieve high level performance, in some 
instances comparable to human experts, in the detection of a range of diseases in  ophthalmology3–5,  radiology6–8, 
 dermatology9,10, and in other fields of medicine. A significant milestone in the clinical application of AI came in 
2018 with the US Food and Drug Administration approval of the IDx-DR system for the autonomous detection 
of referable diabetic retinopathy—the first such approval in any field of  medicine2. Although the application of 
this technology is nascent, it has the potential to transform aspects of  healthcare11.
As is true for any new medical technology, the extent to which AI algorithms for screening, diagnosis or 
prognosis are adopted in medicine will be dependent upon the attitudes of clinicians and patients. Consideration 
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of these attitudes and knowledge gaps will therefore be essential for health systems, medical educators, profes-
sional bodies, AI developers and regulators. Few studies have examined clinician perceptions of new AI tech-
nologies on healthcare provision and the clinical workforce. Those that have been conducted have surveyed the 
potential impacts of AI in samples of medical  students12–14, radiology  trainees15,  radiologists16–18,  pathologists19, 
 psychiatrists20, general practitioners (GP)21, as well as general physicians, surgeons, and  trainees22,23, with 
contrasting results. Most surveys indicate that clinicians believe that AI will have a positive impact on their 
 profession13,16–19,22. Psychiatrists and general practitioners indicated that AI would not affect their  profession20,21. 
In contrast, surveys of medical  students12 and radiology  trainees15 have highlighted concerns about the implica-
tions of AI for training and employment  prospects24–27.
Areas of medicine that are most reliant on imaging will be amongst the first to be impacted by advances in 
AI  technologies28. These include ophthalmology, radiology/radiation oncology and dermatology. In this study 
we conducted a survey of fellows and trainees of these specialty colleges in Australia and New Zealand in order 
to ascertain their current use, understanding and perceptions of AI.
Results
Demographics. A total of 632 trainees and fellows from three specialty colleges (305 ophthalmology, 230 
radiology/radiation oncology, and 97 dermatology) completed the survey (Supplementary Tables 1 and 2). Com-
pleted surveys were received from 20.4% of members of the Royal Australian and New Zealand College of 
Ophthalmologists (RANZCO) (1279 fellows, 212 trainees), 5.1% of members of the Royal Australian and New 
Zealand College of Radiologists (RANZCR) (4505 fellows and trainees) and 13.2% of members of the Australa-
sian College of Dermatologists (ACD) (621 fellows, 113 trainees). RANZCR members included both radiologists 
(n = 199; 86.5% of RANZCR respondents) and radiation oncologists (n = 31; 13.5% of RANZCR respondents). 
ACD respondents were from Australia, whereas RANZCO and RANZCR respondents were from Australia and 
New Zealand. Incomplete surveys (n = 85/717, 11.9%) were excluded from analyses (Supplementary Table 3). 
Responses from completed surveys are summarised in Supplementary Table 4.
Respondents predominantly practiced in metropolitan areas (n = 460, 72.8%), followed by a combination 
of metropolitan and rural practice (n = 102, 16.1%) and rural practice only (n = 70, 11.1%). Ophthalmologists 
were more likely to spend at least part of their time in a rural setting than radiologists/radiation oncologists 
or dermatologists (32.5%, 21.7% and, 23.7% respectively, p = 0.064). Respondents from each group had similar 
years of professional experience (p = 0.608) and almost half of all respondents had been in practice for 20 years 
or more (n = 303, 47.9%) (see Supplementary Table 2).
Current knowledge and use of artificial intelligence in clinical practice. Almost half of respond-
ents (47.6%; n = 301) rated their knowledge of AI as average relative to their peers, with few rating their knowl-
edge as excellent (n = 35, 5.5%) or very poor (n = 31, 4.9%) (Fig. 1; Supplementary Table 4). Responses were 
similar across the three professional groups (p = 0.542). Most respondents indicated that they had never used 
AI applications in their work as a clinician (511, 80.9%). Ophthalmologists were more than twice as likely to 
use AI in their daily clinical practice than radiologists/radiation oncologists or dermatologists (15.7%, 6.1% 
and 5.2%, respectively, p = 0.001) (Fig. 2). Among the 67 ophthalmologists who specified how AI was utilized 
in their clinics, applications included those for glaucoma progression analysis, optical coherence tomography 
assessment, diabetic retinopathy image assessment and intraocular lens (IOL) power calculation (Supplemen-
tary Table  5). Among the 40 radiologists/radiation oncologists who provided details as to how they use AI, 
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Figure 1.  Self-reported knowledge of artificial intelligence and its application in the respondent’s specialty, 
relative to peers in that field.
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applications included those for automated organ and lesion detection using computer aided detection of com-
puted tomography and magnetic resonance imaging (Supplementary Table  5). Among 8 dermatologists, the 
most common applications included those for skin lesion surveillance and voice transcription (Supplementary 
Table 5). Respondents who reported using AI had higher self-reported knowledge of AI than those that did not 
(p = 0.008).
Perceived impact of artificial intelligence on the profession. Most respondents predicted that 
the introduction of AI would improve their field of practice (n = 449, 71.0% agreed or strongly agreed, Fig. 3). 
Almost two thirds (n = 379, 60.0%) of respondents believed that it would be ≤ 5 years before AI had a noticeable 
impact on their specialty (Fig. 4). No respondents reported that AI would never have a noticeable impact on 
their profession. Respondents who reported using AI predicted that the impact would be apparent sooner that 
respondents who did not (p < 0.001).
The majority of respondents (n = 452, 71.1%) reported that AI will impact workforce needs ‘somewhat’ or ‘to 
a great extent’ in these specialty areas of medicine within the next decade. Most (n = 542, 85.8%) respondents 
believed that AI will impact workforce needs ‘somewhat’ or ‘to a great extent’ beyond the next decade. Radiolo-
gists/radiation oncologists were more likely to report workforce needs will be impacted ‘to a great extent’ within 
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Figure 2.  Current frequency of artificial intelligence use in clinical practice.
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Figure 3.  Levels of agreement with the statement “the field of [your specialty] will improve with the 
introduction of artificial intelligence”.
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the next decade than ophthalmologists or dermatologists (54.4%, 41.6%, and 43.3%, respectively, p = 0.04) (Sup-
plementary Table 4; Fig. 5).
The majority of radiologists/radiation oncologists (n = 202, 87.8%) and dermatologists (n = 53, 54.6%) consid-
ered that their medical specialist workforce would be impacted by AI to a greater extent than other health profes-
sionals in their field of practice (such as radiographers or general practitioners). In contrast, ophthalmologists 
considered that the impact of AI on the workforce would be greater for optometrists, than for general practition-
ers or ophthalmologists. Respondents who reported using AI were more likely to report that the introduction of 
AI would lead to the need for an increase in workforce numbers than did those who did not use AI (p = 0.006).
Acceptable artificial intelligence performance standards and clinical workflows. Most survey 
respondents considered that AI systems would need to achieve performance that was superior to the average 
performing specialist when applied to screening for disease (n = 405, 64.1%, Fig. 6A) or for diagnostic decision 
support (n = 506, 80.1%, Fig. 6B).
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Figure 4.  Perceived length of time before artificial intelligence has a noticeable impact on [your specialty].
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Figure 5.  Estimated impact of artificial intelligence on workforce needs within (< 10 years) and beyond 
(> 10 years) the next decade for each specialty group.
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Radiologists/radiation oncologists and dermatologists were twice as likely as ophthalmologists to consider 
that AI screening systems should have error levels superior to the best performing specialist (21.7%, 20.6%, and 
10.5% respectively, p = 0.005, Fig. 6A).
Expectations for system performance were even higher when used for diagnostic decision support by special-
ists. Accordingly, radiologists/radiation oncologists and dermatologists were each more likely than ophthalmolo-
gists to expect AI systems to be superior to the best performing specialist when used for decision support (30.9% 
and 23.9% and 19.0% respectively, p = 0.035, Fig. 6B).
A hypothetical clinical workflow was proposed as follows: “patient clinical images undergo artificial intel-
ligence analysis. A specialist subsequently reviews both the image and the artificial intelligence findings”. Most 
respondents would consider using this clinical workflow, however significantly more ophthalmologists and 
radiologists/radiation oncologists were willing to consider this than dermatologists (82.0%, 82.6%, and 67.0% 
respectively, p < 0.001).
Perceived advantages of the use of artificial intelligence. The top three ranked potential advantages 
of AI were (1) improved patient access to disease screening, (2) improved diagnostic confidence, and (3) reduced 
time spent by specialists on monotonous tasks. The top ranked advantage for ophthalmologists and dermatolo-
gists was ‘improved patient access to disease screening’ and the top ranked advantage for radiologists/radiation 
oncologists was ‘reduced time spent on monotonous tasks’ (Fig. 7).
Concerns about the use of artificial intelligence. The top three potential concerns about the use of AI 
were (1) concerns over the divestment of healthcare to large technology and data companies, (2) concerns over 
medical liability due to machine error, and (3) decreasing reliance on medical specialists for diagnosis and treat-
ment advice. The top ranked concern for ophthalmologists and radiologists/radiation oncologists was ‘concerns 
over the divestment of healthcare to large technology and data companies.’ The top ranked concern for derma-
tologists was ‘concerns over medical liability due to machine error’ (Fig. 8).
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Figure 6.  100% stacked bars showing the acceptable level of error for an AI tool used for (A) disease screening 
and (B) clinical decision support.
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Preparedness for the introduction of artificial intelligence in clinical practice. A minority of 
respondents (n = 87; 13.8%) felt that the specialist training colleges were adequately prepared for the introduc-
tion of AI into clinical practice. Qualitative analysis of a total of 632 open-ended responses was performed, with 
similar responses grouped according to theme. Examples of verbatim responses are provided for each of the top 
five themes in Supplementary Table 6. Many respondents (n = 285) highlighted a need for improved training and 
education of college members about AI via scientific meetings, seminars, and the training curriculum. Some 
respondents highlighted the need for the colleges to be proactive in their approach in order to safeguard member 
interests (n = 99), with one participant requesting the college “make sure any changes are in the best interests of 
patients and [the] profession”. Others endorsed the development of frameworks and/or guidelines for AI imple-
mentation by the colleges (n = 30). The formation of sub-committees and working groups with expertise in AI 
to develop position statements (n = 46) was seen by some as a priority. Other response themes related to colleges 
taking leadership in relation to AI policy development and licensing (n = 74) and to be intimately involved in the 
trial and application of emerging AI systems (n = 69). Others called for the development of measures to ensure 
patient safety (n = 16) and the optimisation of clinical outcomes (n = 17).
Ensuring that patient care remains in the realm of (the specialist) (n = 39) was recognized as a priority. In 
addition, the implementation of measures to assist clinicians in adapting to changes in care delivery (n = 17) 
was reported as a goal, with one respondent stating that this will “assist trainees to prepare for the AI era”. Some 
respondents highlighted a need for colleges to support more AI research (n = 69) and engage with industry, regu-
lators and Government (n = 74). A need for clarity regarding the responsibilities of clinicians who will use the 
technology was also emphasised. Several respondents highlighted the need for a redefinition of the professional 
scope of specialists and related healthcare provider groups as AI is deployed more widely in clinical practice.
Analysis according demographic subgroups. No statistical differences were found for responses based 
on location of practice (metropolitan, rural or both, p > 0.149, Supplementary Table 7). In contrast, differences 
were noted based on years of clinical experience (Supplementary Table 8). Respondents currently in training 
were more than twice as likely than qualified specialists to consider that AI will impact workforce needs ‘to a 
great extent’ within the next decade (p < 0.001), despite no differences in self-reported knowledge of AI and its 
applications between these groups. Similarly, those still in training (n = 44, 66.7%) or with less than 5 years of 
experience as a specialist (n = 41, 66.1%) were more likely to believe that AI would impact practice ‘to a great 
extent’ beyond the next decade than were those with 20–30 years of experience or more than 30 years of experi-
ence (p < 0.001). Those with more than 30 years of experience were less likely to believe that workforce needs 
would decrease compared to those with fewer years of practice (p = 0.007).
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Figure 7.  Radar plot showing the highest scoring responses for the greatest perceived advantages of the use of 
artificial intelligence. Responses were selected from a list of set choices. Plot axes represent the average ranks for 
all respondents, with higher scores indicating a higher ranking/stronger preference.
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Comparison of responses between radiologists and radiation oncologists. Despite the distinct 
clinical roles of radiologists and radiation oncologists, no meaningful differences were detected in responses 
between the two professional groups (p ≥ 0.14), with the exception of knowledge of AI (radiation oncologists 
were more likely to rate their knowledge as below average compared to their peers, p = 0.02) and the number of 
years before AI has a noticeable effect on their field (radiation oncologists were more likely to believe that the 
effect will be noticeable within the next five years, p = 0.01). It is possible that responses from a larger sample of 
specialists in these fields may identify group differences.
Discussion
This survey was conducted to understand the perceptions of ophthalmologists, radiologists/radiation oncologists, 
and dermatologists about AI. These groups were selected as image analysis is a core work task for each profession 
and a variety of AI tools are being developed specifically for these specialties. To our knowledge, this survey is 
one of the first of its kind to investigate these specialist groups in parallel.
Most survey respondents perceived the introduction of AI technology in their respective fields as a positive 
advance. A recent survey of fellows and trainees of the Canadian Royal College of Physicians and Surgeons had 
similar findings: 72.2% of 3,919 respondents indicated that AI would have a positive impact on workflow and/
or clinical practice and patient experience. Only 17.2% of respondents in the Canadian survey indicated that 
AI would have either a negative impact on workflow or place their specialty at risk. These generally positive 
sentiments regarding AI have been echoed across a range of medical specialties in previous  surveys13–16,19,22,23, 
however, surveys of general  practitioners21 and of  psychiatrists20 have indicated that the potential of AI may be 
limited for these groups. Similar to our findings, low rates of clinical AI use by radiologists/radiation oncologists 
have previously been reported, indicating that AI has not yet been widely adopted in this  field15,16. However, it 
is possible that AI use is underreported in surveys such as this due to a lack of visibility of algorithms that are 
deployed within imaging platforms or variations in the interpretation of what constitutes AI.
Most respondents considered that AI will have a noticeable impact on clinical practice within the next 5 years 
and on workforce needs within the next decade. In contrast, participants with more years of clinical experience 
were less likely to believe AI would have an impact on workforce needs within and beyond the coming decade, 
and current AI users were more likely to believe that workforce needs would increase. The current survey did not 
explore the basis for these diverging opinions. A survey of radiologists in the United States reported that AI would 
dramatically influence professional duties, however, the impact on workforce numbers was not  ascertained15. 
Other surveys have indicated that workforce needs would remain stable or increase over the coming decade 
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Figure 8.  Radar plot showing the highest scoring responses for the perceived concerns or drawbacks of the use 
of artificial intelligence. Responses were selected from a list of set choices. Plot axes represent the average ranks 
for all respondents, with higher scores indicating a higher ranking/stronger preference.
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despite the introduction of  AI16,18. Understanding the basis for these different perceptions on the impact of AI 
on the future medical workforce may be an interesting subject for further study.
Improved access to disease screening was reported by ophthalmologists and dermatologists as the greatest 
perceived advantage to the use of AI. Recognition of the need for increased disease screening capacity may be 
explained by the combined effects of workforce maldistribution in regional and rural areas versus urban areas 
and projected increases in the burden of diseases, such as diabetic retinopathy and skin cancer, due to population 
ageing and  growth29,30. The perceived advantage of reducing time on monotonous tasks by radiologists/radia-
tion oncologists is not surprising given the large and growing volume of images viewed by these practitioners. 
Other studies have similarly identified reduced administrative burden and decreased image interpretation time 
as advantages of AI use for primary care  physicians21 and  pathologists16.
The adoption of AI tools by clinicians is likely to be influenced by the extent to which they can be integrated 
into clinical workflows, enhance efficiency and achieve acceptable levels of  performance31. The standards set by 
regulators of AI applications for health may not be directly aligned with the expectations of clinicians in practice. 
Interestingly, dermatologists were less accepting of a proposed clinical workflow which included AI-assisted diag-
nosis. This may be attributable to the distinct clinical practices of  dermatologists31. Survey respondents had uni-
versally high expectations of AI system performance. There are many examples of AI outperforming  humans1,2, 
however, until this study, little was known of the level of performance clinicians expect from AI systems.
In keeping with high expectations for AI system performance, respondents were concerned about medical 
liability due to machine error. Legal processes for dealing with harms arising from new technologies have evolved 
in parallel with innovation, however the legal, moral and ethical considerations are increasingly challenging as 
technologies become more  autonomous32,33. Lessons learned from autonomous vehicle technologies may provide 
some guidance, but this remains an area for further research and broad-based  consultation33,34.
An additional concern of respondents was a reduced reliance on medical specialists as a consequence of AI 
adoption. This concern is consistent with the impact of the technology on future workforce needs reported in this 
and other  studies15,16,19. It is interesting that the primary concern of respondents was the divestment of healthcare 
to large technology companies. General mistrust in large technology companies has been documented  recently35 
and specifically in relation to  healthcare36. Accordingly, numerous survey respondents called for leadership 
from specialist colleges and representative bodies to educate their members and to contribute to frameworks 
for the development, adoption and regulation of AI technologies in healthcare. The recent survey of fellows and 
residents conducted as part of the Canadian Royal College of Physicians and Surgeons Taskforce Report on Arti-
ficial Intelligence and Emerging Digital Technologies, similarly indicated that digital health literacy standards 
should be introduced and that governing bodies should take a proactive approach to  AI23. Respondents called 
for improved training and education to improve awareness of AI and to increase proficiency in data science and 
statistics. Needs for training in ethics and legal aspects of AI ranked second to basic AI proficiency for  fellows23.
The limitations of this survey warrant consideration. Volunteer response bias means that the results may not 
be broadly representative of the views of clinicians in Australia and New Zealand. Moreover, the survey may not 
be generalizable beyond these countries. As response rates from radiologists/radiation oncologists and derma-
tologists were low, it is not possible to ascertain whether the views of respondents are representative of others in 
these specialty groups. Finally, the survey design imposes limitations on the scope of response options and thus 
the survey findings should not be regarded as a comprehensive account of the perceptions of respondents. This 
limitation was mitigated by the inclusion of open-ended questions.
In conclusion, this survey highlights major similarities between the perceptions of ophthalmologists, radi-
ologists/radiation oncologists and dermatologists in Australia and New Zealand about the application of AI in 
medicine. Overall, AI was regarded as a means to improve patient access to care, as well as to enhance clinical 
efficiency and performance. Concerns were raised about the influence of large technology and data companies, 
implications for medical liability and reduced reliance on medical specialists. As the successful implementation 
of AI in healthcare is dependent on detailed understanding of clinician and patient expectations of the technol-
ogy, further research in these domains is needed.
Methods
This prospective anonymous online survey was approved by the Human Research Ethics Committee of the Royal 
Victorian Eye and Ear Hospital (HREC 18-1408HL) and was conducted in accordance with the doctrines of 
the Declaration of Helsinki and its subsequent revisions. Electronic informed consent was obtained from each 
participant online prior to survey commencement.
Survey design. Study data were collected and managed using REDCap electronic data capture tools hosted 
at the Centre for Eye Research Australia. Survey questions were developed after a review of previous survey lit-
erature and in consultation with ophthalmologists, radiologists and dermatologists to ensure face validity. Exam-
ple scenarios and related occupational fields differed between surveys designed for each specialty. Draft surveys 
were circulated to executives from the RANZCO, the RANZCR and the ACD for testing. The survey consisted 
of 18 multiple choice and open-ended questions (Supplementary Table 1). An additional question was included 
for radiologists and radiation oncologists to enable differentiation between these professional groups. Questions 
focused on frequency of AI use, knowledge, workforce impact, preparedness for future AI implementation, 
acceptable levels of error, individual concerns and barriers. Survey invitations were emailed by college staff to 
all fellows and trainees of the colleges residing in Australia and New Zealand. Dermatology respondents were 
from Australia alone. Participation in this anonymous survey was voluntary and no incentives were provided.
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Data analysis. Multiple choice questions were analysed using Stata (v15.1, StataCorp, College Station, 
Texas). A complete-case analysis was conducted (i.e., incomplete surveys were excluded from the analyses, see 
Supplementary Table 3). Responses were compared according to profession, location of practice and years of 
experience using the Pearson’s χ2 test. Two-sided significance testing was conducted with an alpha of 5%. The-
matic analysis of the response to “What do you think the college should do in preparation for the deployment 
of AI?” was undertaken using a ‘bottom up’ approach. Two authors (PR and XH) generated a list of initial 
codes after reviewing responses. Codes were built into broader categories and recurring themes were developed. 
Thematic discrepancies were resolved via discussion. Responses to questions regarding advantages and disad-
vantages of AI were analysed as follows: the first preference of each respondent received a score of 3, the second 
preference a score of 2 and the third preference a score of 1. Scores were tallied for each response and divided by 
the number of respondents to provide an overall score for each response. Higher scores indicate higher rankings. 
Scores were displayed as radar plots (Figs. 7, 8).
Data availability
The authors declare that the data supporting the findings of this study are available within the paper and the 
supplementary information files. Raw data are available upon request.
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